Pavel Strnad is an Associate Professor and Senior Physician at the University Hospital Aachen, Aachen, Germany. He currently leads a European initiative for the study of AATD-associated liver disease.
Mark L. Brantly is a Professor of Medicine and Chief of Molecular Genetics and Microbiology in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Florida College of Medicine in Gainesville (FL, USA), where he is also the Alpha-1 Foundation Research Professor.
Robert Bals is Director of the Saarland University's (Saarbrucken, Germany) Department of Pulmonolgy, where he focuses on teaching, research and patient care. He established and manages the German AAT Registry.